vimarsana.com

Latest Breaking News On - Aoife brennan - Page 3 : vimarsana.com

Why Synlogic (SYBX) Stock Is Down Nearly 50% Today - Synlogic (NASDAQ:SYBX)

Synlogic shares are trading lower by 48.4% to $1.78 Friday afternoon. The company announced it will discontinue Synpheny-3, cease operations and reduce its workforce by more than 90%.

Aoife brennanSynlogic inc

Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update

Synlogic Announces Decision to Discontinue Synpheny-3 Study and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United kingdomAoife brennanData monitoring committeeExchange commissionSynlogic incSynlogic presidentChief executiveExplore strategicChief executive officerPrivate securities litigation reform act

Synlogic (SYBX) to Discontinue Synpheny-3 Study and Provides Corporate Update

Synlogic (SYBX) to Discontinue Synpheny-3 Study and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Aoife brennanData monitoring committeeSynlogic incSynlogic presidentChief executiveExplore strategicChief executive officer

Synlogic Shares Tumble 55% on Discontinued Trial, Halt to Operations

By Ben Glickman Shares of Synlogic fell sharply after the company opted to cease operations after stopping a clinical trial. The stock was down 55% to $1.56.

Aoife brennanBen glickmanChief executive aoife brennanArticle normalBiotechnology servicesHealthcare life sciencesFinancial performanceShare price movement disruptionsNew products servicesResearch developmentCorporate industrial newsProducts servicesNew product service testingContent typesFactiva filtersC amp ampe exclusion filter

Synlogic to Cease Operations, Cut Almost All Employees After Ending Trial

By Ben Glickman Synlogic on Thursday said it would cease operations and cut nearly all of its workforce after ending its study of a potential treatment for.

United kingdomAoife brennanBen glickmanExecutive aoife brennanArticle normalBiotechnology servicesHealthcare life sciencesLabor personnelCorporate industrial newsLay offs redundanciesContent typesFactiva filtersC amp ampe industry news filterIndustrial newsLay offsLife sciences

vimarsana © 2020. All Rights Reserved.